Frontiers journals are at the top of citation and impact metrics
The rapidly increasing amount of genome data provides wide opportunities to address new research questions and to translate new knowledge in clinical practice. However, translating research ideas to knowledge and then into clinical practice is a slow, multistep process that needs to be based on scientific rigor in all phases. Currently, most mature areas for clinical applications include rare disease diagnostics, oncology, infectious diseases and pharmacogenomics. We expect that the next wave is seen in improving our understanding of chronic diseases that change traditional diagnostic categories. These new disease classifications hopefully result in new, more tailored treatment and prediction options.
Genomic Medicine welcomes manuscripts from all steps of the translation process, from basic research to clinical applications. These can include methodological, experimental, clinical and laboratory diagnostic topics, potential targeted therapies that use genome information, strategies for genetic risk prediction in both common and rare diseases, methods and strategies in biobanking, electronic health records, mining of clinical data, methods and strategies for monitoring and predicting disease trajectories.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), EMBASE, AGRICOLA, Semantic Scholar, Ulrich's Periodicals Directory, Science Citation Index Expanded, BIOSIS Citation Index, Biological Abstracts, CLOCKSS, EBSCO, OpenAIRE, Zetoc, Mastermind
Genomic Medicine welcomes submissions of the following article types: Book Review, Brief Research Report, Case Report, Clinical Study Protocol, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology Report.
All manuscripts must be submitted directly to the section Genomic Medicine, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Genomic Medicine will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Genetics.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org